A mathematical model of intermittent androgen suppression for prostate cancer

From MaRDI portal
Revision as of 19:58, 2 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:2391253


DOI10.1007/s00332-008-9031-0zbMath1172.92021MaRDI QIDQ2391253

Gouhei Tanaka, Takumi Takeuchi, Aiko Miyamura Ideta, Kazuyuki Aihara

Publication date: 24 July 2009

Published in: Journal of Nonlinear Science (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s00332-008-9031-0


65C20: Probabilistic models, generic numerical methods in probability and statistics

37N25: Dynamical systems in biology

92C50: Medical applications (general)


Related Items

Method of directly defining the inverse mapping applied to prostate cancer immunotherapy — Mathematical model, Stability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancer, The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy, Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells, Bifurcation Analysis of Mathematical Model of Prostate Cancer with Immunotherapy, Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer, Nonlinear systems identification by combining regression with bootstrap resampling, MATHEMATICAL MODELING OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION WITH PARTIAL DIFFERENTIAL EQUATIONS, A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor, Modeling the effects of chemotherapeutic dose response on a stochastic tumor-immune model of prostate cancer with androgen deprivation therapy, Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model, Numerical convergence and stability analysis for a nonlinear mathematical model of prostate cancer, Selection of prostate cancer therapy strategy under early androgen suppression treatment, A nonlinear competitive model of the prostate tumor growth under intermittent androgen suppression, A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy, A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy, Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer, Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer, Ability of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patients, A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer, Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer, Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer, Parameter identification of a model for prostate cancer treated by intermittent therapy, Periodic and chaotic dynamics in a map-based model of tumor-immune interaction, Threshold dynamics of a stochastic model of intermittent androgen deprivation therapy for prostate cancer, Intermittent hormone therapy models analysis and Bayesian model comparison for prostate cancer, Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives, PCa dynamics with neuroendocrine differentiation and distributed delay, Dynamics of a non-smooth model of prostate cancer with intermittent androgen deprivation therapy, On tumoural growth and treatment under cellular dedifferentiation, Dynamic behavior of stochastic prostate cancer system with comprehensive therapy under regime switching, Dynamics and implications of models for intermittent androgen suppression therapy, Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy, Analysis of mathematical model of prostate cancer with androgen deprivation therapy, A time scales approach for modeling intermittent hormone therapy for prostate cancer, Modeling the effect of immunotherapies on human castration-resistant prostate cancer, Androgen driven evolutionary population dynamics in prostate cancer growth, Practically scheduling hormone therapy for prostate cancer using a mathematical model, Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis, Comparison between mathematical models of intermittent androgen suppression for prostate cancer, Avoiding healthy cells extinction in a cancer model, A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics, Stationary distribution and persistence of a stochastic mathematical model for prostate cancer with pulsed therapy, Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer, Dynamical Aspects of a Hybrid System Describing Intermittent Androgen Suppression Therapy of Prostate Cancer, Dynamics of an HBV Model with Drug Resistance Under Intermittent Antiviral Therapy, Combination of singularly perturbed vector field method and method of directly defining the inverse mapping applied to complex ODE system prostate cancer model, A MODEL AT THE MACROSCOPIC SCALE OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION



Cites Work